Karen Davis | Center for Structural Biology /csb Mon, 16 Nov 2026 16:43:20 +0000 en-US hourly 1 https://cdn.vanderbilt.edu/vu-wpfsx/wp-content/uploads/sites/79/2026/06/cropped-CSB-Logo-wh-bkgnd-512x512-1-32x32.png Karen Davis | Center for Structural Biology /csb 32 32 Alexia Angelos wins the 2027 Dr. Anne Karpay Award in Structural Biology /csb/2026/11/13/2027-karpay-award-winner-alexia-angelos/ Fri, 13 Nov 2026 17:44:13 +0000 /csb/?p=9027
Alexia Angelos, Yi Ren Lab

Congratulations to Alexia Angelos, a 5th-year PhD candidate in the Yi Ren lab, on being named the 2027 recipient of the Dr. Anne Karpay Award in Structural Biology. “Receiving the Karpay Award is a tremendous honor,� Angelos said. “I’ve looked up the previous winners since joining Vanderbilt. It’s a privilege now to be counted among them.�

Alexia always thought biology was fascinating, but she wasn’t sure she wanted to pursue it as a career until she joined the lab of Dr. Doris D’Souza as a sophomore at the University of Tennessee Knoxville. There she found her calling studying the inactivation of Murine Hepatitis Virus (MHV), a surrogate virus for SARS-CoV-2, using novel ultraviolet light disinfection systems and natural products. She subsequently graduated from UTK with a BS in Microbiology, a minor in Hispanic Studies and an undergraduate thesis (Novel Ultraviolet Light Technologies for the Inactivation of Murine Hepatitis Virus, a SARS-CoV-2 Surrogate) completed for the Chancellor’s Honors Program.

Eager to expand her horizons, Alexia completed a summer internship at Medical University of South Carolina studying protein-protein interactions in Vaccinia Virus in the lab of Dr. Paula Traktman. It was at MUSC that Alexia decided to focus her research career on the basic science of protein interactions.

Since coming to Vanderbilt, Alexia has built an impressive track record. In Professor Ren’s lab, she has spearheaded collaborations with the Montpetit lab at UC Davis and the Fontoura lab at UT Southwestern testing the structural and biochemical findings of her thesis project on the structural and functional characterization of the conserved TREX-2.1 complex and its binding partner Sub2, a key enzyme in mRNP remodeling in splicing and export.

Alexia visits Greece

“Since joining our lab, Alexia has made significant contributions to the field of mRNA processing and nuclear export,� Professor Ren said. “She’s highly organized and demonstrates mentorship and service within the lab and the Department of Biochemistry.�

When she’s not conducting research, serving with the Biochemistry Postdoctoral Researcher and Student Association, mentoring undergrads or helping to plan departmental retreats, Alexia can be found experimenting with new recipes, reading, traveling or spending time with her orange cat, Leo.

Alexia will present her Karpay Award talk, Functional Divergence in Proteins and PhDs, on Tuesday, January 19, 2027, as part of the MBTP/CSB Seminar Series. The seminar begins at 12:00pm in 1220 MRB3 with the award presentation and reception to follow.

The Dr. Anne Karpay Award in Structural Biology was established in 2010 to honor the memory of Dr. Anne Karpay, who died after a four-year battle with breast cancer. It is funded entirely by donations to an endowment managed through the Development Office of the Vanderbilt University School of Medicine.

]]>
9027
CSB Spotlight: Karasmanis Lab /csb/2026/10/22/csb-spotlight-karasmanis-lab/ Thu, 22 Oct 2026 12:38:38 +0000 /csb/?p=8985 Becoming a Principal Investigator can feel agonizingly slow during the interview process, yet the leap itself is instantaneous—like being thrown into the deep end of the pool and told to swim!

The CSB is shining the spotlight on new labs by following their journey to starting a lab at Vanderbilt.

Today, we meet Biological Sciences Assistant Professor and CSB PI Eva Karasmanis. While the journey was worthwhile, it wasn’t always straightforward. From Greece to Music City, learn about her challenges in setting up a new lab, especially scavenging old labs for leftover supplies.

Meet the Karasmanis lab!


What does your lab work on?ÌýWe study the mechanisms of intra- and intercellular transport. How do cells get materials to the right place at the right time? How do molecular motors Ìý(the cell’s moving trucks) “knowâ€� where to pick up their cargo and where to take it? And how doÌýcells adapt this transport machinery to traffic materials not just within themselves, but to each other? We want to understand how cells organize and regulate their transport machinery across scales, from individual molecular motors to communication between cells.

Eva Karasmanis, Principal Investigator, (left) and Dimitrios Angelis, Lab Manager, scavenging supplies from the empty lab space of a former PI

What are the primary tools and techniques you use to answer these questions?ÌýWe use a combination of cell biology, advanced fluorescence microscopy (e.g. spinning-disk confocal, TIRF, super-resolution microscopy), quantitative live-cell imaging, biochemistry, and in vitro reconstitution. We also use cryo-electron tomography (cryo-ET) to see how transport machinery is organized in its native cellular environment.

By being able to move between scales, we can build complexity with control. We can Ìýwatch something happen in a living cell, break it down to understand the underlying molecular mechanism, and then use structural approaches to see how those pieces are actually organized inside cells.

What was your path to this position?ÌýI grew up in Greece and was attracted to cell biology pretty much as soon as I learned what a cell was (in fourth grade!), but research is not exactly a secure career path back home. I was fated to become a chemical engineer. Except…I HATED IT. In fairly dramatic late-teen fashion, and very much against my parents’ wishes, I retook our national exams so I could pursue Molecular Biology and Genetics instead. I joined a cell biology lab during my junior year, where I mostly worked on protein purification and biochemical assays. As soon as I saw my first microscopy image, I was in love.

Eva Karasmanis, assistant professor of biological sciences and of physics and astronomy
College of Arts and Science (Vanderbilt University)

I knew I wanted to pursue a PhD in cell biology and decided to try my luck in the United States. Thankfully, I was blissfully unaware of just how weak my application probably looked! My PhD advisor, Dr. Elias Spiliotis saw something in it, interviewed me for the Biological Sciences program at Drexel University, and admitted me. I had a strong PhD experience, made some fun discoveries, obtained NIH funding, and became particularly enthralled by the sheer amount of movement happening inside cells.

The questions I wanted to ask though—How does stuff move? How is that movement regulated?—demanded a deeper molecular and mechanistic understanding. So, for my postdoc, I joined the lab of HHMI Investigator Dr. Samara Reck-Peterson, where I studied dynein activation using cryo-EM, in vitro reconstitution, and yeast genetics. But my love of discovery has always been rooted at the cellular level, which made me increasingly curious about cryo-electron tomography. Around the same time, I became fascinated by evidence that cells can transport material directly to one another through controversial structures called tunneling nanotubes. Cryo-ET seemed like the perfect tool to ask some very basic questions: Are these tunnels actually open? And what is inside them? I trained in Dr. Elizabeth Villa’s lab to learn the technique and was ultimately able to answer the questions I had set out to investigate.

That combination of tools and my persistent curiosity about how cellular transport systems work, eventually drove me onto the faculty job market. I chose Vanderbilt because the people here seem genuinely collaborative. People are kind and willing to carve time out of very busy schedules to help one another, and the barriers to reaching across departments and colleges are remarkably low. If anything, the possibilities can feel overwhelming! I feel incredibly lucky to be in such a supportive environment, with thoughtful infrastructure (like the CSB!) that can help us realize our scientific vision.

Eva filling an empty lab with the aspirations of a thriving research program

What is your favorite part of being a PI so far?ÌýSo far, one of the most enjoyable and slightly surreal parts has been talking science with colleagues and realizing that I’m now a peer rather than a trainee. But what I’m most looking forward to is working with trainees. We’re working hard to get the lab fully up and running so that we can offer meaningful rotation experiences. A major reason I wanted to become a PI was the opportunity to build a healthy lab culture and watch people discover the joy of discovery for themselves, while developing both as scientists and as people. I’m actually looking forward to that even more than the creative freedom I now have in my own science!

Dimitrios hanging out in Nashville

What are some fun activities you like to do?ÌýI love reading books and playing video games. These days I’m deliberately keeping my reading light and consuming a lot of romance novels. The world feels dark and troubling enough without my recreational reading adding to it! I also think video games are one of the peaks of human creativity. They can be visually stunning, and I love solving puzzles and methodically working my way through quests in a completely made-up world. I also have two small children, so much of my free time is spent with them, coaxing them to discover the world. We love hiking, particularly when there is some kind of water payoff at the end—a lake, waterfall, swimming hole, a beach, anything along those lines!

Any surprises?ÌýOne surprise has been just how instantaneous the transition to being a PI feels. There are no training wheels! You go from working in fully equipped labs, where almost everything you need is already available, to standing in an empty space and realizing that even the simplest experiment requires an enormous amount of preparation. Starting a lab can therefore feel both daunting and occasionally lonely, but it has also given me a new appreciation for how much thought and work goes into creating the environment where science can happen. We’re building that environment piece by piece, and I’m very excited to see what grows in it.

]]>
8985
A Halloween interview with Nobel laureate Jacques Monod /csb/2026/10/08/a-halloween-interview-with-nobel-laureate-jacques-monod/ Thu, 08 Oct 2026 17:35:31 +0000 /csb/?p=8951
Nobel laureate Jacques Monod

This interview was first published in October 1, 2026 issue of Under the Microscope published by The Protein Society. It is reprinted here with the author’s permission.

Jacques Monod was born in 1910, earned his PhD from the University of Paris in 1941, joined the Pasteur Institute in 1943, and shared the 1965 Nobel Prize in Physiology or Medicine with Pasteur colleagues François Jacob and André Lwoff. He passed away in 1976. CSB Chief Spirit Communicator Chuck Sanders reached out to Dr. Monod through the Transylvanian communication portal. Let’s listen in on the conversation:


Chuck: Dr. Jacques Monod, it is SUCH an honor to meet you! I can only hope to ask you questions worthy of the life you lived!

Jacques: Don’t be silly. I am happy to meet a fellow scientist. Things in the biomolecular world just keep getting more and more interesting, don’t they?

Chuck: I agree! But first let me say that you are confirming what I noticed when I watched some old videos of you being interviewed: not only is your English flawless, it is nearly accent-free. If I did not know you were French, I might have a hard time placing it!

Jacques: I have my upbringing to thank for that. My mother was from Milwaukee, the daughter of a Scottish immigrant. How’s your French?

Chuck: Trés pauvre, I am afraid. That is, except for the song “Chevaliers de la Table Ronde.� In high school I was going to get a C in French but my teacher said if I memorized and sang all 6 verses in front of the class, she’d give me a B. Best drinking song ever written!

Jacques: Ha ha! But I know at least 12 verses, so you got off easy. I agree that It is a good song!

Chuck: You yourself were quite a musician. I heard that early in your graduate career (this would have been in the late 1930s) you were invited to Caltech for a 1-year fellowship. But when you got there, you did more conducting than science. I heard that you almost took a job as a conductor in LA. True?

Jacques: Well, music was always a big part of my life. I especially like Bach’s choral music. You know, for a while he was writing a new cantata every week—you have to respect that! There’s something about his music thatÌýstirs the scientific mind, or at least it does mine. But you mentioned Caltech. Maybe I didn’t do much science on my first visit there, but I did make connections there that endured over the years.

Chuck: You completed your Ph.D. in 1941 on how bacteria respond to growth on glucose/lactose mixtures, work that eventually paved the way for the characterization of the lac operon that led to your Nobel Prize. I think it is funny that at your Ph.D. defense your lab director told you that while you did pass, “Your work is of no interest to the Sorbonne.�

Jacques: As one of the suffragettes said, “It is as equally useless to be ahead of your time as it is to be behind the times.� But it all worked out.

Chuck: You were young—still a student—when you married Odette. You guys had twins in 1939. Since Odette was Jewish things must have gotten super scary when Nazi Germany invaded France in 1940.

Jacques: Indeed, it was a difficult time. Odette and the kids went to live in the country, posing as Gentiles.

Chuck: But not you. You continued your career as a scientist in Paris, secretly joining the French resistance to do what could be done to covertly undermine the Nazis. Your code name was Malivert. My understanding is that by the time D-Day rolled around, you were Chief of Staff of a major resistance unit and giving orders to blow up bridges and railroads.Ìý You had friends doing resistance work who were uncovered and tortured, killed outright, or sent to concentration camps.Ìý Where did you find the courage?

Jaques: My father’s family, going Ìýseveral hundred years back, were Huguenots and so there was a tradition of persisting in difficult circumstances. Maybe I inherited a knack for survival from them, and it definitely helped that I had like-minded friends who took similar risks. In any case, from deep down inside I could not be satisfied with sitting on the sidelines.

Chuck Sanders, Chief Spirit Communicator

Chuck: I am filled with admiration. It is so easy just to lay low and hope the storm will pass.

After the war, you went back to the lab. While much of your service in the resistance was associated with communist entities, you never really embraced communism, and after the war you rejected it completely. I read that a major factor in this decision was that you were disgusted by Lysenkoism. Can you tell us a little about this?

Jacques:Ìý Trofim Lysenko was the leading Soviet biologist from the time when Stalin consolidated his power in the late ‘20s allÌý the way into the 1960s under Kruschev. You would call him a quack. I would call him a canard. He did not believe in Mendelian genetics and, even after the work of Avery, Watson, and Crick, he did not believe in genes. But both his political views and whacky biological ideas were well-aligned with hardline Marxism. So, Stalin made sure he ran the show in Soviet biology. If you publicly disagreed with him in Russia or other Soviet states, there was a good chance you’d be shot. Some of his plant biology ideas led to enforced farming Ìýpractices that contributed to famines in the Ukraine and later in China that resulted in tens of millions of deaths. Non, merci! I did what I could to make sure La France declined to buy into such a travesty, and I think I was pretty successful.

Chuck:ÌýMutual rejection of communism also led to your friendship with Albert Camus, right?

Jacques: Yes. That, plus the bond of having both been involved in the resistance, although we did not know each other then. Albert now sings in my chorale.

Chuck: ÌýÌýOK…Ìý I want to ask more, but it is against the rules.

I cannot help but ask you about one other major adventure in your life. A young Hungarian scientist, Agnes Ullman, became so enamored with the work you and Jacob were pursuing that she wanted to defect, but not without her husband. The problem was that this was shortly after the Hungarian revolution of 1956, which was savagely put down by Russia and its local proxies.Ìý If Agnes and her husband had been caught trying to escape, they might have been executed.Ìý My understanding is that you schemed for months and committed large sums of your own moneyÌý plus funds from colleagues to pay for schemes to get Dr. Ullman and her husband out.Ìý Eventually (1958), you arranged their escape from the Iron Curtain by smuggling them out in a camper-trailer.Ìý They were almost discovered when the Hungarian guards on the Austrian border searched the camper in which they were hidden in a storage bin.Ìý But they made it out and Ullman not only joined the Jacob lab but went on to take the posts of Research Director and Head of Biochemistry at the Pasteur.Ìý Honestly, you can’t make this stuff up.Ìý It’s like you were the James Bond of science!

Jacques: Thank you. I always liked the Brits. Agnes Ullman was a very determined woman. Her thirst for freedom was exceeded only by her love of science.

Chuck: Your work with Jacob led to the first conceptualization of how genes can be regulated: the lac operon. With your genius for English you coined the terms “operon� and “operator.� You and Jacob also participated in the multinational team effort that led to recognition of the existence and importance of “messenger RNA,� yet another term you introduced. Should I mention that you also came up with the term “allostery?�

Anyways, well before you won the Nobel Prize you were hanging out with Delbrück, Watson, Luria, Brenner, Crick and other pioneers of molecular biology. The tale is well-told in The Eighth Day of Creation by Horace Judson, who got to know most of the pioneers personally, including you. One thing that comes through in that book is the sense that this extraordinary circle of scientists, who met at Cold Spring Harbor every summer, seemed to be a little clubby. Did it seem that way to you?

Jacques: Times were different then. The gap between the elite scientists and everyone else was much greater then than now. Largely because of grant policy changes made in post-WWII America at the urging of people like Vannevar Bush, science is much more democratized now. This means it is harder now to predict where the next big discovery will come from. I think that’s good. It also helps one to understand the “club� culture of elite molecular biology back in the early 1950s.

Chuck: Interesting! Thanks.

Returning to science, one of your other paradigm-establishing discoveries was made by you and two of your colleagues: the Monod-Wyman-Changeux (MWC) model for protein allostery, which was published in 1964-1965. I have the pleasure of teaching this every year to the medical students when I do my lecture on hemoglobin. The idea is that most allosteric interactions are based on the fact that proteins can exist in interconverting tertiary and/or quaternary structural states and that allosteric molecules exert their impact on protein function by binding preferentially to the state associated with activity (for activators) or inactivity (for inhibitors). This shifts the structural equilibrium one way or the other according to physiological need. ÌýOne manifestation of this concept is often referred to as “conformational selection.â€� It is such a common phenomenon in biology! Your model may also have been the first to recognize the functional importance of the intrinsic dynamics of proteins. Indeed, permit me to note that the Protein Society is hosting a whose roots can be traced back to your work: The Dynamic Nature of Allostery.

Jacques:Ìý Well, let me just point out that the bulk of the credit here should go to my former grad student Jean-Pierre Changeux. A fantastic student who went on to a long and distinguished career!

Chuck: Dr. Monod, I’d like to wrap up by noting that after you won the Nobel Prize you became a very public figure in France.Ìý You wrote a book, Chance and Necessity, that not only explained in lay terms your scientific understanding of life, but also its philosophical implications. Maybe I can summarize your conclusion by quoting a song, “Scientist,â€� by one of my favorite bands, The Dandy Warhols. The punchline of this song is, “We’ve got to live on science alone!â€�

Jacques: Yes, I know the Dandy Warhols. From Portland, right? I don’t think the Dandys have published many papers on proteins!

Chuck: I don’t think they go to church either.

Jacques:ÌýHa ha! Then we have a lot in common!

Chuck: That’s just the point. Your book sold quite well in France—this was 1970.Ìý In some ways it was as if you had taken on the mantle of your late friend, Camus, in pondering whether there is a basis for human decency even in a universe that you believed to be utterly indifferent to humankind.Ìý I don’t claim to know anything about 20th century French philosophy, but this strikes me as a difficult matter. You conclude your book with an eloquent summary: “The ancient covenant is in pieces; man knows at last that he is alone in the universe’s unfeeling immensity, out of which he emerged only by chance. His destiny is nowhere spelled out, nor is his duty. The kingdom above or the darkness below; it is for him to choose.â€�

Let me just close by saying that there is no question about which choice you made and then repeatedly confirmed throughout your life. What an honor it has been to meet you!

Jacques: It has been a pleasure. And by the way, I almost forgot—Happy 10th Anniversary to the School of Medicine Basic Sciences! And Happy Halloween to the Center for Structural Biology!

Chuck: Merci Jacques! Over and out!

Jacques: A demain!

—

Acknowledgements

CS thanks Becky Sanders and Wade Van Horn for edits and helpful comments. You can learn more about Jacques Monod in Brave Genius (by Sean Carroll), The Eighth Day of Creation (by Horace Judson), and in Anges Ullman’s “In Memorium� (Genome Biol. Evol. 3:1015-1033, 2010). Read previous Halloween Interviews at the and check out the . This interview is AI-free and is a slightly edited version of the same interview published in the Protein Society Newsletter.

 

]]>
8951
Machine learning reveals how genetic variants disrupt a cardiac ion channel /csb/2026/10/01/machine-learning-reveals-how-genetic-variants-disrupt-a-cardiac-ion-channel/ Thu, 01 Oct 2026 14:53:42 +0000 /csb/?p=8926 Genetic testing can identify mutations linked to disease, but discovering a variant doesn’t always reveal what it means for a patient. Many genetic changes are classified as variants of uncertain significance, and even variants predicted to be harmful can disrupt proteins in very different ways.

A by Ana Chang-Gonzalez and colleagues shows how machine learning could help move genetic medicine from simply predicting whether a variant is dangerous to explaining how it causes disease.

The researchers focused on KCNQ1, a potassium channel that helps the heart maintain a normal electrical rhythm. Mutations in KCNQ1 are a major cause of congenital long QT syndrome (LQTS), an inherited condition that can lead t0Ìýdangerous cardiac arrhythmias.

Chang-Gonzalez et al., (2026) Structural model of KCNQ1 based on PDB 8SIK used to generate biophysical features. Variants used for training and cross-validation studies are mapped onto the structure. Spheres represent variant Cα atoms. Variants functionally characterized for this study are colored dark purple. VSD = voltage-sensing domain. PD = pore domain. HA, HB, HC = intracellular helical domains. S4 variants are not included in the mapping.

Importantly, KCNQ1 mutations do not all cause disease through the same mechanism. Some prevent enough channel protein from reaching the cell surface, a process called mistrafficking, while others reach the membrane normally but fail to conduct electrical current or open and close properly.

To distinguish these mechanisms, the researchers trained machine-learning models using experimental measurements from 201 KCNQ1 variants with functional data and 145 with trafficking data. Rather than producing a single prediction of pathogenicity, the models predict seven properties of the channel, including electrical current, channel opening and closing, and protein trafficking to the cell surface. The key was combining broad machine learning predictions with detailed knowledge of KCNQ1. The models incorporated information from tools such as AlphaMissense, ESM-2 and ProteinMPNN alongside features describing the channel’s three-dimensional structure, evolution and biophysical properties. Together, these sources generally performed better than either approach alone. This added detail proved particularly useful for difficult variants.

When tested on 23 ClinVar variants of uncertain significance that had been excluded from training, the models predicted their functional effects better than AlphaMissense and an earlier KCNQ1-specific predictor. The researchers also developed overall dysfunction and mistrafficking scores that helped separate variants annotated as benign from those considered pathogenic.

Ana Chang-Gonzalez, PhD

The broader promise is precision medicine. A patient whose mutation prevents KCNQ1 from reaching the cell surface might benefit from a drug that restores trafficking, whereas someone whose channel reaches the membrane but functions poorly could require a treatment that increases channel activity. The study notes that a small-molecule trafficking corrector has already been identified for certain KCNQ1 variants, suggesting that such mechanism-specific therapies are becoming plausible.

Important challenges remain. The training dataset is relatively small and imbalanced, and the current models cannot reliably distinguish loss-of-function from gain-of-function effects, a distinction that will be essential for clinical use. Still, the significance extends well beyond KCNQ1. The study provides a framework for combining general machine learning models with targeted biological experiments to predict not just whether a mutation is harmful but to explain why.

The same strategy could potentially be adapted to other ion channels and disease-associated proteins. As genetic sequencing makes variants easier to discover, approaches like this could help solve the harder problem, turning genetic information into biological understanding, and ultimately into more personalized treatments.

]]>
8926
Call for applications: The Dr. Anne Karpay Award in Structural Biology /csb/2026/09/17/call-for-applications-the-dr-anne-karpay-award-in-structural-biology/ Thu, 17 Sep 2026 18:32:59 +0000 /csb/?p=8879
Anne Karpay, PhD

The Karpay Award Committee is now soliciting applications for the 2027 Dr. Anne Karpay Award in Structural Biology.

This award was established in 2010 to commemorate Dr. Anne Karpay, whose studies focused on membrane protein structural biology under the guidance of Professors Chuck Sanders and Tina Iverson. Dr. Karpay’s career ended prematurely following a 4-year battle with breast cancer, which claimed her in 2008.

The winner will be chosen based on their scientific accomplishments in the area of structural biology. It is equally important that the award winner is a well-roundedÌýcolleague, who is collegial and collaborative, traits that defined Dr. Karpay.

A $1,500 honorarium accompanies the award, which is contingent upon the winner giving the MBTP/CSB seminar in January, when the award will be presented.

Applications will be accepted until 3pm, October 23, 2026. The winner will be notified by November 9, and the award itself will be presented on January 19, 2027 as part of the MBTP/CSB Seminar Series. Send completed application materials to Karen Davis.

The most recent Karpay Award winners include:

  • Kate Clowes Moster (2026, Sanders Lab)
  • Jenny Tran (2025 º£½ÇÖ±²¥, Breann Brown Lab)
  • Eli McDonald (2024, Meiler/Plate Labs)
  • Ivette Perez (2023 (Iverson Lab)
  • Noah Bradley (2022 Eichman Lab)
  • A complete list of winners can be found on the Karpay Award webpage

We wish all the applicants the best of luck in competing for this award!


Make a Difference

Dare to make a difference by to help continue this tradition of the Vanderbilt structural biology community.

]]>
8879
Novel structural insights reveal how human IP3R-2 receptors control calcium release /csb/2026/09/10/novel-structural-insights-reveal-how-human-ip3r-2-receptors-control-calcium-release/ Thu, 10 Sep 2026 15:36:54 +0000 /csb/?p=8841 Inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) control calcium (Ca²�) signals by tightly regulating the spatial and temporal release of Ca²� from stores within the endoplasmic reticulum into the cytosol of the cell while bound to IP3. Ca²� is an important second messenger ion that has roles in a variety of physiological processes in the body, notably cell apoptosis, gene expression, and muscle contraction, and its dysregulation disrupts function, leading to disease.

There are three subtypes of IP3R (IP3R-1–3), which share around 60–70% amino acid conservation and assemble as homo- or heterotetramers, forming one of the largest intracellular ion channel complexes at ~1.2 MDa. While the sequence identity of the IP3R subtypes is high, they still possess distinct spatiotemporal expression patterns and physiological properties. IP3R-2 exhibits the highest affinity for IP3, is more sensitive to potentiation by ATP (which acts as a regulator of IP3R), and IP3R-2 channels tend to support cell-wide Ca²� oscillations rather than the large, sustained Ca²� transients seen in other subtypes such as IP3R-3.

Erkan Karakas, Associate Professor
Molecular Physiology and Biophysics

CSB researchers Caifeng Liu and Erkan Karakas report the cryo-EM structures of human IP3R-2 (hIP3R-2) in distinct conformations in the presence and absence of IP3, Ca²â�º, and ATP in a recently published Nature Communications paper.ÌýHere, they while defining compact (apo, resting, and preactivated), loose (inactive-like), and asymmetric intermediates.

 

In a nominally Ca²â�º-free environment, hIP3R-2 was shown to adopt a homotetrameric, mushroom-shaped assembly.Ìý3D refinement of the compact class with C4 symmetry yielded a high-quality map at 2.95 Ã… overall resolution and resembled the low-Ca²â�º structures of rat IP3R-1 and human IP3R-3.

Consensus cryo-EM maps of hIP3R-2 at ligand-bound resting (a), intermediate state 3 (b), intermediate state 4 (c), and preactivated state (d), as shown in the publication.

However, the loose conformation was remarkably flexible and retained weak cytosolic intersubunit contacts; refinement strategies that improved the compact class did not markedly improve this class. Each subunit shares a conserved domain architecture with other IP3R subtypes, comprising two β-trefoil domains (βTF1/2), three Armadillo repeat domains (ARM1–3), a central linker, a zinc-finger–containing juxtamembrane domain (JD), a transmembrane domain (TMD), and a C-terminal domain. The TMD forms a closed channel with a pore constriction radius of ~0.7 Å, flanked by lipid-like densities and conserved extra helices (S1′/S1″). Compared to hIP3R-3, apo hIP3R-2 displays subtle structural variations, most notably an ARM2 domain tilted further toward adjacent subunits and a flexible, disordered self-binding peptide region near the IP3-binding pocket.

Cryo-EM structures of hIP3R-2 bound to IP3 and ATP show a clear activation pathway driven by specific domain movements. When IP3 binds, the receptor undergoes a small local change, with the ARM1 domain rotating ~4° toward βTF2. The protein then moves into a preactivated state where the ARM2 domain pulls back toward the channel-like domain, and ARM1 rotates an additional 16° to fully close the cleft. Reconstructions of asymmetric intermediate states reveal that these domain movements can occur independently within individual subunits. However, ARM2 movement in one subunit directly correlates with cleft closure in its neighbor, proving that subunits communicate with each other during activation.

Although hIP3R-2 follows an activation path similar to other isoforms, its response to calcium is unique. In datasets containing IP3, ATP, and calcium, calcium density is visible at the primary activation site between ARM3 and the JD. Despite this binding, the channels remain in a loose, inactive-like shape rather than opening their pores. Unlike hIP3R-3, no extra calcium-binding sites were detected. Because local flexibility can hide weak calcium density, these structures conservatively represent either desensitized or calcium-inhibited states, showing that calcium binding at the activation site does not automatically open the pore. These structures also explain how receptors interact with one another when exposed to IP3, ATP, and calcium.

Caifeng Liu, Researcher
Karakas Lab

Neighboring channels form dimers and larger assemblies through a cytosolic interface made of ARM1 and βTF1 domains. This interface only opens after ligand-driven domain shifts occur, meaning it is absent in the apo or IP3/ATP states. The transmembrane domains of adjacent channels align along a flat plane, making this arrangement fully compatible with resting side-by-side in the ER membrane, unlike previous hIP3R-3 dimer models, which would distort the lipid bilayer. Ligand binding acts as a trigger to expose the ARM1-βTF1 interface, driving direct channel clustering that underlies localized calcium puffs. Mutating this contact site with the G706K mutation stops channels from clustering without altering their individual structure or gating activity. This mutation provides a precise tool to separate spatial clustering from channel function in future calcium signaling research.

This paper presents the cryo-EM structures of hIP3R-2 conformations in the presence and absence of IP3, Ca²�, and ATP and demonstrates that IP3R channels can self-assemble without needing accessory proteins or cytoskeletal anchors. By mapping the conformational landscape, ligand binding, and inter-channel assemblies of IP3R-2, their findings establish the structural basis of its gating and spatial organization.

The Karakas lab concludes with the statement that integrating these structural insights with further research in electrophysiology, helper factor identification, and cross-isoform comparisons will be essential to fully resolve IP3R-mediated Ca²� dynamics.

 

]]>
8841
Microscopy STEM education—Reaching the masses in Milwaukee /csb/2026/08/27/microscopy-stem-education-reaching-the-masses-in-milwaukee/ Thu, 27 Aug 2026 15:59:09 +0000 /csb/?p=8787
Juleen Dickson, CSB Cryo-EM Staff Scientist

The (MSA) recently held its annual Microscopy and Microanalysis Conference in Milwaukee, Wisconsin.

The conference showcased exciting efforts to build microscopy STEM networks across the state, with the CSB’s Cryo-EM Staff Scientist Juleen Dickson leading the charge.

The MSA’s X93 program, chaired by Dickson, partnered with Discovery World, Hitachi and ZEISS, introduced local students to hands-on microscopy.

Students analyze samples using the electron Hitachi Electron microscope at Discovery World.
Photo: Juleen Dickson

Students collected samples—including pollen, rocks and native insects—from the Lake Michigan shoreline and examined their findings using both electron and light microscopes, generously provided by ZEISS and Hitachi.

Students collect samples along the Lake Michigan shoreline.
Photo: Juleen Dickson

This initiative marks an important step toward expanding electron microscopy access throughout Wisconsin with Discovery World serving as a hub to distribute Hitachi’s environmental SEM across the state.

Want to get involved? Join the MSA education outreach effort.

]]>
8787
A new class of lipid raft disruptors /csb/2026/08/13/a-new-class-of-lipid-raft-disruptors/ Thu, 13 Aug 2026 14:54:22 +0000 /csb/?p=8694 Biological membranes are highly dynamic and varied structures which contain compact ordered domains or “rafts� of lipids and proteins within the otherwise disordered membrane “sea.� These lipid rafts serve as functional microdomains that cluster specific receptors and signaling molecules to influence membrane trafficking, signaling pathways, neurotransmission, and membrane fluidity. However, lipid raft formation and the processes which mediate ordered phase/disordered phase partitioning of biological membranes are not well understood.

Katherine Stefanski, PhD, Sanders Lab

published in PNAS, the , led by post-doctoral fellow Katherine Stefanski, aims to better characterize these mechanisms by identifying pharmacological agents which alter membrane dynamics.

The authors first conducted a high-throughput screen to identify small molecules which modulate the partitioning of human peripheral myelin protein 22 (PMP22), a protein which preferentially clusters in lipid rafts. Giant plasma membrane-derived vesicles (GPMVs) were purified out of HeLa cells expressing PMP22, exposed to a 23,360 compound library, and compounds which alter PMP22 partitioning were identified. Compounds were further screened against GPMVs from cells expressing myelin and lymphocyte protein (MAL), another lipid-raft preferring protein in order to identify nonprotein-specific small molecules. Of the compounds remaining, the researchers then identified a unique group of small molecules, specifically VU0615562 and VU0619195, which reduced the partitioning of PMP22 and MAL, disrupted lipid raft formation, and somewhat paradoxically, had increased activity in the presence of raft-favoring membrane proteins.

To validate this interesting chemical behavior, the authors exposed HeLa-cell derived GPMVs containing PMP22 or MAL to proteinase K, a serine protease which cleaves proteins, and found that the efficacy of VU0615562 and VU0619195 to disrupt lipid formation was reduced. Furthermore, GMPV radii, relative ordered domain size, and lipid symmetry were unchanged, indicating the effects of these compounds were specific to the presence of raft-favoring proteins. Both compounds, however, were shown to increase the membrane fluidity of GPMVs, with VU0619195 having a more pronounced effect than VU0615562.

Chuck Sanders, PhD
Photo by Joe Howell

The researchers then sought to determine if this behavior was the result of a direct interaction between the chemical compounds and PMP22 or MAL. NMR indicated that both VU0615562 and VU0619195 interact with PMP22, albeit weakly. To better understand the impact of this interaction, the authors then turned to another raft-favoring protein, TRPM8, an ion channel protein whose function is directly tied to membrane order. NMR also indicated that VU0619195 interacted weakly with TRPM8 and treatment of HeLa cells with VU0619195 reduced the activity of TRPM8 as seen by automated patch clamp electrophysiology.

Altogether, this study provides the first examples of a class of compounds with the unique properties of disrupting lipid formation, inhibiting protein partitioning into rafts, and exhibiting heightened activity in the presence of raft-favoring proteins. Additionally, while the compounds act in a manner enhanced by raft proteins, their activity is not totally dependent on them, making VU0615562 and VU0619195 very versatile tools for future study of lipid raft dynamics. Finally, both VU0615562 and VU0619195 were shown to be much less toxic to model cell lines than comparable compounds which will allow future researchers to study biological membranes in a much less disruptive background.

 

]]>
8694
A Molecular Blueprint for Bacterial DNA Repair /csb/2026/07/23/a-molecular-blueprint-for-bacterial-dna-repair/ Thu, 23 Jul 2026 14:56:19 +0000 /csb/?p=8661 Every day, the DNA of living organisms is exposed to damage from normal cellular processes, environmental toxins, and even some medicines. Among the most dangerous forms of damage are interstrand DNA crosslinks (ICLs), chemical bonds that effectively staple the two strands of DNA together and prevent cells from reading, copying, or repairing their genetic information.

While scientists have long known that bacteria possess mechanisms to repair these lesions, exactly how they recognize and remove them has remained unclear.

In a new study, the and the provide , a DNA repair enzyme found in several disease-causing bacteria, revealing how it detects and repairs these potentially lethal DNA crosslinks.

Using X-ray crystallography, the researchers captured AlkX bound to damaged DNA, allowing them to visualize the molecular interactions that occur during repair. The structure revealed specialized regions of the enzyme that grip DNA and identify the damaged site. Through a combination of structural biology, biochemical experiments, and bacterial growth studies, the researchers demonstrated that these regions are essential for repair. When key components of AlkX were altered, the enzyme lost much of its ability to recognize and remove DNA crosslinks, leaving bacteria significantly more vulnerable to DNA-damaging chemicals.

The findings are particularly relevant because AlkX-like enzymes are widespread among important human pathogens, including Acinetobacter baumannii, Salmonella enterica, Listeria monocytogenes, and Pseudomonas aeruginosa. A. baumannii is considered one of the world’s most concerning antibiotic-resistant pathogens and is a major cause of hospital-acquired infections. Previous work showed that AlkX helps this bacterium survive stressful conditions encountered during infection, but the new study explains the molecular basis for that protective effect.

The researchers also identified a naturally occurring genetic variant in an antibiotic-resistant strain of Salmonella that disrupts AlkX function, demonstrating how structural insights can help explain the consequences of genetic mutations in pathogenic bacteria.

Beyond revealing the workings of a single enzyme, the study advances our understanding of how microbes maintain the integrity of their genomes under extreme stress. It also highlights DNA repair pathways as potential targets for future antimicrobial therapies.

By disabling enzymes such as AlkX, researchers may one day be able to weaken bacterial defenses, making dangerous pathogens more susceptible to DNA damage and less capable of causing infection. As antibiotic resistance continues to rise worldwide, uncovering vulnerabilities in bacterial survival mechanisms represents an important step toward developing new strategies to combat hard-to-treat infections.

Together, these findings provide a molecular blueprint for how bacteria repair some of the most toxic forms of DNA damage and open new avenues for understanding pathogen survival and developing next-generation antibacterial treatments.

 

]]>
8661
Green Team visits Rand Dining Hall /csb/2026/07/09/green-team-visits-rand-dining-hall/ Thu, 09 Jul 2026 15:09:41 +0000 /csb/?p=8537
Green Team members left to right: Borden Lacy, Georgia Caso, Karen Davis, Gabrielle Fortier, Lily Van Ye, Sam Insignares (photo by Chelsea Hamilton)

For most labs, lunch is the most sacred part of the day—a time to fuel up after a long morning of experiments, rant about the latest failed experiments, brainstorm new ideas and peer pressure each other into signing up for running races.

If you forget (or simply don’t have time) to pack a lunch, a lot of biomedical science students turn to Suzie’s, Starbucks, Panera or the VUMC cafeteria. But when told that Vanderbilt dining halls have taken considerable actions to implement food sustainability, the members ofÌýtheÌýGreen Team jumped at the opportunity to learn what Vanderbilt Campus Dining, specifically Rand Hall, is all about!

During a meal at Rand Dining Hall, followed by a tour from Campus Dining’s Suzanne Herron, sustainability coordinator, and Kip Bennett, master gardener, Green Team members learned about alumni-sourced lettuce, reusable container programs, worms that eat leftovers and much more!

The Food

  • Master Gardener Kip Bennett points out lettuces being grown hydroponically. (photo by Borden Lacy)

    Red meat is served less often, and seafood and vegetarian options have been expanded. Burgers are 75% beef, 25% mushroom!

  • (previously Creation Gardens), the main distributor for campus dining, prioritizes local and regional products.
  • , founded by alumnus Hassan Sharraff in 2016 and located in Hermitage, Tennessee, provides leafy greens year-round through hydroponic production!
  • Hydroponic lettuce and leafy greens are also grown right in the dining hall (Tower Gardens, installed 2021).
  • º£½ÇÖ±²¥ is part of the , which promotes healthier and sustainable food choices!

The Food Waste

  • ReusePass is a program to get reusable containers in any Vanderbilt dining hall.
  • Vanderbilt Campus Dining has negotiated with vendors to have zero single-waste plastics in any on-campus facilities.
  • Dining facilities weigh all leftover food items and use waste tracking to identify patterns of food waste. The AI-powered platform delivers insight used to adjust menus and amounts of food made each day.
  • Component of worm tower used by Campus Dining (photo by Borden Lacy)

    Leftover food is donated to local food pantries and shelters!

  • Dining facilities sort all food waste and compost any leftover food. They have a closed-loop compost collaboration with in Ashland City, Tennessee, to collect pre- and post-consumer food waste for compost; some of the compost is brought back to campus for the flower beds! Kip Bennett diverts some food waste to his “worm towerâ€� where worms decompose food scraps into nutrient rich soil that is used in on-campus gardens.

The Facility

  • From the second floor of Sarratt Student Center, a blooming rooftop pollinator garden can be seen benefiting the native birds, insects and bees while promoting biodiversity and sustainability goals.
  • The VanderBees initiative installed two new honeybee hives that thrive off the pollinator garden and native flora on campus. Hopefully some honey can be harvested soon!
  • Sam Insignares chats with Chelsea Hamilton during the Green Team excursion (photo by Borden Lacy)

    While admiring the buzzing bees from behind the windows, underfoot are 60 that generate energy to illuminate the path while walking down the hallway. This installation provides a hands-on learning experience connecting individuals to Vanderbilt’s sustainability visions.

The Verdict

The Green Team suggests that you give the sustainable dining experience at Rand Hall a go the next time you meet with colleagues or want to try something new! You might be surprised not only by the food but that a simple dining choice can have a positive impact on the planet!

 

]]>
8537